A 66 per cent-owned subsidiary of ASX-listed Proteomics International Laboratories has picked up a major win in the world’s most populous market after being granted a Chinese patent for its potentially revolutionary muscle stress test.
Developed alongside The University of Western Australia, OxiDx Limited’s technology uses a quick, low-cost fingerprick blood test to track muscle damage caused by oxidative stress in elite athletes and thoroughbred racehorses.
